Luminex gets FDA emergency approval for Zika test

Top Priority Sector: federal_agencies_legislativeAUSTIN, TX Aug. 8, 2016 Luminex Corporation (NASDAQ: LMNX) today announced that it has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for a multiplex nucleic acid test designed to detect Zika virus RNA in potentially infected patients using their blood serum, plasma, or urine (collected alongside a patient-matched serum or plasma specimen).Homepage position: 1read more